in

Durvalumab Boosts Survival in Muscle-Invasive Bladder Cancer

Source link : https://www.newshealth.biz/health-news/durvalumab-boosts-survival-in-muscle-invasive-bladder-cancer/

BARCELONA — Adding the immune checkpoint inhibitor durvalumab to standard treatment for muscle-invasive bladder cancer (MIBC) significantly improved survival, reducing the risk for death by 25%, according to a preplanned interim analysis of the phase 3 NIAGARA trial. These results offer practice-changing evidence in an area of unmet need, said lead investigator Thomas Powles, MD, […]

Author : News Health

Publish date : 2024-09-17 13:10:37

Copyright for syndicated content belongs to the linked Source.

Companies Behind Malta Hospital Controversy Spent Millions on Luxuries, Payments to Director | OCCRP – OCCRP

How the Gulf States Are Exerting Their Influence in Africa – New Lines Magazine